CLINICAL_TRIALS
trial_result
· 2018-10-16
Clinical Trial Update: ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa [Phase 3]
Summary
Phase 3 trial updates for SD-101 cream in Epidermolysis Bullosa have been completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Scioderm, Inc. | Conditions: Epidermolysis Bullosa | Phase 3 | Status: COMPLETED | Results posted: 2018-10-16